Bladder cancer
Conditions
Interventions
Index test:Near infrared peptide probe. The equipment models are as follows: 28164 AC, 28164 BC, 28164 FC
Camera host. The equipment models are as follows: GCYJ-F04M-090002
Cold light source. The equipment models are as follows: GCYJ-F23G-090004.
Sponsors
Harbin Medical University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. The patients who have fully understood the study and voluntarily signed the written informed consent; 2. Patients with bladder tumor diagnosed by pathology and scheduled for surgical treatment; 3. Patients aged 18-70 years old, regardless of gender; 4. Those with KPS score >= 60; 5. The patients with normal organ function (without continuous support treatment, the laboratory examination results within one week before admission); neutrophils > 1.5 x 10^9 / L, platelets > 100 x 10^9 / L, hemoglobin > 9.0g/dl; normal or < 1.5 x ULN bilirubin; ast (SGOT), ALT (SGPT) < 2.5 x ULN (if liver metastasis, < 5 x ULN); serum creatinine < 1.5 x ULN; 6. Patients with an estimated survival time of 3 months or more.
Exclusion criteria
Exclusion criteria: 1. Patients with urinary system malformation or urethral stricture; 2. Pregnant or lactating subjects; 3. Patients with other serious systemic diseases; 4. Patients who are allergic to a variety of drugs; 5. Those who are participating in or have participated in another clinical study within the last 30 days;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fluorescence intensity of bladder tumor;Accuracy ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity ;Specificity ;Positive predicative value; | — |
Countries
China
Contacts
Public ContactWanhai Xu
Harbin Medical University Cancer Hospital
Outcome results
None listed